Home/Filings/4/0001209191-19-030722
4//SEC Filing

TICHENOR MCHENRY T 4

Accession 0001209191-19-030722

CIK 0001426332other

Filed

May 16, 8:00 PM ET

Accepted

May 17, 11:47 AM ET

Size

5.8 KB

Accession

0001209191-19-030722

Insider Transaction Report

Form 4
Period: 2019-05-15
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-05-15+24,00024,000 total
    Exercise: $13.35Exp: 2029-05-14Common Stock (24,000 underlying)
Footnotes (2)
  • [F1]Issued pursuant to the Amended and Restated 2018 Equity Incentive Plan.
  • [F2]The stock option shall vest in four (4) approximately equal quarterly installments, such that the option shall be fully vested on the earlier of (i) the one-year anniversary of the date of grant and (ii) the day prior to the next Issuer's annual stockholder meeting held after the effective date of the initial public offering, subject to the Reporting Person's Continuous Service (as defined in the Amended and Restated 2018 Equity Incentive Plan) on each applicable vesting date.

Issuer

NGM BIOPHARMACEUTICALS INC

CIK 0001426332

Entity typeother

Related Parties

1
  • filerCIK 0001034497

Filing Metadata

Form type
4
Filed
May 16, 8:00 PM ET
Accepted
May 17, 11:47 AM ET
Size
5.8 KB